Related references
Note: Only part of the references are listed.17β-estradiol-induced growth of triple-negative breast cancer cells is prevented by the reduction of GPER expression after treatment with gefitinib
Rainer Girgert et al.
ONCOLOGY REPORTS (2017)
Structural and Molecular Mechanisms of Cytokine-Mediated Endocrine Resistance in Human Breast Cancer Cells
Joshua D. Stender et al.
MOLECULAR CELL (2017)
Genetic Modification of Oncolytic Newcastle Disease Virus for Cancer Therapy
Xing Cheng et al.
JOURNAL OF VIROLOGY (2016)
Neo-tanshinlactone selectively inhibits the proliferation of estrogen receptor positive breast cancer cells through transcriptional down-regulation of estrogen receptor alpha
Wanjun Lin et al.
PHARMACOLOGICAL RESEARCH (2016)
Activated human mesenchymal stem/stromal cells suppress metastatic features of MDA-MB-231 cells by secreting IFN-β
N. Yoon et al.
CELL DEATH & DISEASE (2016)
Inhibition of ERα/ERK/P62 cascades induces autophagic switch in the estrogen receptor-positive breast cancer cells exposed to gemcitabine
Peng Shen et al.
ONCOTARGET (2016)
Antiestrogen Resistant Cell Lines Expressing Estrogen Receptor α Mutations Upregulate the Unfolded Protein Response and are Killed by BHPI
Chengjian Mao et al.
SCIENTIFIC REPORTS (2016)
The BCL-2 protein family, BH3-mimetics and cancer therapy
A. R. D. Delbridge et al.
CELL DEATH AND DIFFERENTIATION (2015)
Oncolytic Newcastle disease virus as a prospective anti-cancer therapy. A biologic agent with potential to break therapy resistance
Volker Schirrmacher
EXPERT OPINION ON BIOLOGICAL THERAPY (2015)
Estrogen regulates Hippo signaling via GPER in breast cancer
Xin Zhou et al.
JOURNAL OF CLINICAL INVESTIGATION (2015)
Estradiol induces HOTAIR levels via GPER-mediated miR-148a inhibition in breast cancer
Sifeng Tao et al.
JOURNAL OF TRANSLATIONAL MEDICINE (2015)
Action of methyl-, propyl- and butylparaben on GPR30 gene and protein expression, cAMP levels and activation of ERK1/2 and PI3K/Akt signaling pathways in MCF-7 breast cancer cells and MCF-10A non-transformed breast epithelial cells
Anna Maria Wrobel et al.
TOXICOLOGY LETTERS (2015)
Antineoplastic activity of Newcastle disease virus strain D90 in oral squamous cell carcinoma
Chun-Xiao Zhang et al.
TUMOR BIOLOGY (2015)
SIRT1 is involved in oncogenic signaling mediated by GPER in breast cancer
M. F. Santolla et al.
CELL DEATH & DISEASE (2015)
Newcastle disease virotherapy induces long-term survival and tumor-specific immune memory in orthotopic glioma through the induction of immunogenic cell death
Carolien A. Koks et al.
INTERNATIONAL JOURNAL OF CANCER (2015)
Inhibition of GPR30 by estriol prevents growth stimulation of triple-negative breast cancer cells by 17β-estradiol
Rainer Girgert et al.
BMC CANCER (2014)
Genetically engineered Newcastle disease virus expressing interleukin-2 and TNF-related apoptosis-inducing ligand for cancer therapy
Fu-Liang Bai et al.
CANCER BIOLOGY & THERAPY (2014)
α-Mangostin-induced apoptosis is mediated by estrogen receptor α in human breast cancer cells
Yeong-Seon Won et al.
FOOD AND CHEMICAL TOXICOLOGY (2014)
GPER mediates enhanced cell viability and motility via non-genomic signaling induced by 17β-estradiol in triple-negative breast cancer cells
Tenghua Yu et al.
JOURNAL OF STEROID BIOCHEMISTRY AND MOLECULAR BIOLOGY (2014)
Estradiol regulates Tumor Necrosis Factor-α expression and secretion in Estrogen Receptor positive breast cancer cells
Sarah Q. To et al.
MOLECULAR AND CELLULAR ENDOCRINOLOGY (2014)
Estrogen and pure antiestrogen fulvestrant (ICI 182 780) augment cell-matrigel adhesion of MCF-7 breast cancer cells through a novel G protein coupled estrogen receptor (GPR30)-to-calpain signaling axis
Yan Chen et al.
TOXICOLOGY AND APPLIED PHARMACOLOGY (2014)
Oncolytic therapy of a recombinant Newcastle disease virus D90 strain for lung cancer
Zheng Chai et al.
VIROLOGY JOURNAL (2014)
Mitophagy promotes replication of oncolytic Newcastle disease virus by blocking intrinsic apoptosis in lung cancer cells
Gang Meng et al.
ONCOTARGET (2014)
Links between oestrogen receptor activation and proteolysis: relevance to hormone-regulated cancer therapy
Wen Zhou et al.
NATURE REVIEWS CANCER (2014)
STAT3 interacts with Skp2/p27/p21 pathway to regulate the motility and invasion of gastric cancer cells
Zheng Wei et al.
CELLULAR SIGNALLING (2013)
Downregulation of Skp2 inhibits the growth and metastasis of gastric cancer cells in vitro and in vivo
Zheng Wei et al.
TUMOR BIOLOGY (2013)
Inactivation of GPR30 reduces growth of triple-negative breast cancer cells: possible application in targeted therapy
Rainer Girgert et al.
BREAST CANCER RESEARCH AND TREATMENT (2012)
Oncolytic Newcastle disease virus for cancer therapy: old challenges and new directions
Dmitriy Zamarin et al.
FUTURE MICROBIOLOGY (2012)
Targeting Inhibitors of Apoptosis Proteins (IAPs) For New Breast Cancer Therapeutics
Shaomeng Wang et al.
JOURNAL OF MAMMARY GLAND BIOLOGY AND NEOPLASIA (2012)
The G Protein-Coupled Receptor GPR30 Inhibits Proliferation of Estrogen Receptor-Positive Breast Cancer Cells
Eric A. Ariazi et al.
CANCER RESEARCH (2010)
Mitochondria and cell death: outer membrane permeabilization and beyond
Stephen W. G. Tait et al.
NATURE REVIEWS MOLECULAR CELL BIOLOGY (2010)
Estrogen Promotes Breast Cancer Cell Survival in an Inhibitor of Apoptosis (IAP)-dependent Manner
Adina Stanculescu et al.
Hormones & Cancer (2010)
Breast Cancer, Estrogen Receptor and Ligands
Zhenlin Bai et al.
ARCHIV DER PHARMAZIE (2009)
An optimized clinical regimen for the oncolytic virus PV701
Sebastien J. Hotte et al.
CLINICAL CANCER RESEARCH (2007)
Phase 1 clinical experience using intravenous administration of PV701, an oncolytic Newcastle disease virus
Robert M. Lorence et al.
CURRENT CANCER DRUG TARGETS (2007)
Functional estrogen receptors in the mitochondria of breast cancer cells
A Pedram et al.
MOLECULAR BIOLOGY OF THE CELL (2006)
Phase I/II trial of intravenous NDV-HUJ oncolytic virus in recurrent glioblastoma multiforme
AI Freeman et al.
MOLECULAR THERAPY (2006)
MTH-68/H oncolytic viral treatment in human high-grade gliomas
LK Csatary et al.
JOURNAL OF NEURO-ONCOLOGY (2004)
Caspases, IAPs and Smac/DIABLO: mechanisms from structural biology
EN Shiozaki et al.
TRENDS IN BIOCHEMICAL SCIENCES (2004)
Share Paper
